Sivik Global Healthcare’s Quest Diagnostics DGX Stock Holding History

Sivik Global Healthcare’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,000	Closed	-$3.81M	–	51
2025 Q3	$3.81M	Sell	20,000 -5,000	-20%	-$887K	1.11%	37
2025 Q2	$4.49M	Buy	+25,000	New	+$4.34M	1.22%	31
2024 Q1	–	Sell	-30,000	Closed	-$4.14M	–	49
2023 Q4	$4.14M	Buy	+30,000	New	+$3.94M	1.73%	31
2021 Q4	–	Sell	-6,000	Closed	-$3.63M	–	49
2021 Q3	$3.63M	Buy	+6,000	New	+$878K	0.87%	40
2020 Q4	–	Sell	-50,000	Closed	-$5.72M	–	42
2020 Q3	$5.72M	Sell	50,000 -75,000	-60%	-$8.86M	2.46%	22
2020 Q2	$14.2M	Buy	+125,000	New	+$13.3M	4.72%	1
2020 Q1	–	Sell	-27,500	Closed	-$2.94M	–	47
2019 Q4	$2.94M	Sell	27,500 -22,500	-45%	-$2.35M	1.09%	40
2019 Q3	$5.35M	Buy	50,000 +20,000	+67%	+$2.05M	2.7%	19
2019 Q2	$3.05M	Buy	+30,000	New	+$2.88M	0.74%	43
2018 Q4	–	Sell	-40,000	Closed	-$4.32M	–	55
2018 Q3	$4.32M	Buy	40,000 +10,000	+33%	+$1.1M	1.54%	31
2018 Q2	$3.3M	Buy	+30,000	New	+$3.13M	1.27%	39
2017 Q4	–	Sell	-20,000	Closed	-$1.87M	–	72
2017 Q3	$1.87M	Buy	+20,000	New	+$2.12M	0.64%	58
2016 Q3	–	Sell	-45,000	Closed	-$3.66M	–	52
2016 Q2	$3.66M	Buy	+45,000	New	+$3.43M	1.82%	25
2016 Q1	–	Sell	-50,000	Closed	-$3.56M	–	60
2015 Q4	$3.56M	Buy	50,000 +20,000	+67%	+$1.34M	1.69%	26
2015 Q3	$1.84M	Hold	30,000	–	–	0.89%	47
2015 Q2	$2.18M	Sell	30,000 -40,000	-57%	-$2.95M	0.76%	52
2015 Q1	$5.38M	Sell	70,000 -34,000	-33%	-$2.43M	1.83%	17
2014 Q4	$6.97M	Buy	104,000 +10,800	+12%	+$682K	2.82%	6
2014 Q3	$5.66M	Buy	93,200 +20,000	+27%	+$1.23M	2.57%	7
2014 Q2	$4.3M	Buy	73,200 +34,668	+90%	+$2.03M	2.17%	18
2014 Q1	$2.23M	Buy	+38,532	New	+$2.07M	1.39%	32

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sivik Global Healthcare's DGX Position: Q4 2025 in Review

Sivik Global Healthcare sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 20,000 shares — an estimated $3.81M sold.

Sivik Global Healthcare first reported a position in DGX in Q1 2014 and held it in 21 quarters. The position peaked at $14.2M in Q2 2020. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

Sivik Global Healthcare reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
Sivik Global Healthcare sold 20,000 Quest Diagnostics shares in Q4 2025, an estimated $3.81M.
Sivik Global Healthcare first reported a position in Quest Diagnostics in Q1 2014 and held it in 21 quarters.
Sivik Global Healthcare's Quest Diagnostics position peaked at $14.2M in Q2 2020.
1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Sivik Global Healthcare's 13F filing for Q4 2025, filed 21 Jan 2026.